# DESCRIPTION

## FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT

## FIELD OF THE DISCLOSURE

## BACKGROUND OF THE DISCLOSURE

## SUMMARY OF THE DISCLOSURE

## DETAILED DESCRIPTION OF THE INVENTION

### Diagnosis of Dry Eye Disease

### CCR7 Antagonist(s)

### CCL19 and CCL21 Ligands

### Methods of Use

### Ophthalmic Formulations

### Example 1

### Example 2

### Other Embodiments

